Strategic Narrative Alignment for Biotech, Pharma, & Medtech
We help biotech, pharma, and medtech organisations maintain alignment between science, strategy, and capital as products move through regulatory, medical, market access, commercial, and investment scrutiny.
Using our Narrative Integrity Framework™, we align evidence, claims, value, and communication before regulators, HTA bodies, investors, and markets apply scrutiny.
Supporting biotech, pharma, and medtech organisations across Europe, North America, and beyond.
What We Do
We help life science organisations make better decisions by keeping evidence, strategy, and stakeholder communication aligned throughout the product lifecycle.
Rather than operating as a task-based vendor, we work as a senior extension of your team, reducing decision risk, maintaining narrative integrity, and supporting critical regulatory, medical, market access, commercial, and investment milestones.
We help life science organisations make better decisions by keeping evidence, strategy, and stakeholder communication aligned throughout the product lifecycle.
Rather than operating as a task-based vendor, we work as a senior extension of your team, reducing decision risk, maintaining narrative integrity, and supporting critical regulatory, medical, market access, commercial, and investment milestones.
How We Support the Product Lifecycle
Delivered through Amodaia’s proprietary Narrative Integrity Framework™, our senior specialists align evidence, strategy, and communication before regulators, HTA bodies, investors, and markets apply scrutiny.
About Us
Amodaia is a senior-led life science consultancy helping biotech, pharma, and medtech organisations maintain alignment between science, strategy, and capital.
Every engagement is led by experienced specialists who combine scientific expertise with practical regulatory, medical, market access, commercial, and investor insight.
Our principle is simple:
Alignment before acceleration.
Problems We Solve
Life science leaders rarely struggle because of a lack of science.
They struggle because narrative, evidence, and strategy drift apart under pressure.
As development accelerates, functions specialise. Regulatory, medical, access, marketing, and capital conversations evolve in parallel, often without a single, disciplined narrative holding them together.
Under scrutiny, that drift becomes visible.
We help teams resolve the structural tensions that emerge across the product lifecycle:
- Decision and Prioritisation Pressure
- Cross-Functional Misalignment
- Science That Doesn’t Translate
- Compressed Timelines, Elevated Scrutiny
- Fragmented Vendor Models
Amodaia exists to maintain one coherent, defensible product truth, from evidence generation through commercialisation and capital events.
Why We Are Different
We are not a legacy medcomms agency or generalist shop. We are lean, senior, and focused on outcomes that move your business forward.
- Senior-led specialists with direct accountability
- Cross-functional perspective across the product lifecycle
- Governance beyond document delivery
- Human judgement enhanced by modern technology
- Built for regulatory, payer, and investor scrutiny
We are not a legacy medcomms agency or generalist shop. We are lean, senior, and focused on outcomes that move your business forward.
- Senior-led specialists with direct accountability
- Cross-functional perspective across the product lifecycle
- Governance beyond document delivery
- Human judgement enhanced by modern technology
- Built for regulatory, payer, and investor scrutiny